Alzheimer clinical trials

Explore recruiting alzheimer clinical trials.

Recruiting alzheimer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Alzheimer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Allogeneic adipose tissue derived-stem cells in Alzheimer disease

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 2a/2b Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of MK-1942 as Adjunctive Therapy in Participants with Mild to Moderate Alzheimer’s Disease Dementia

Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants with Early Alzheimer's Disease

Spain, Belgium, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE)

Italy, Bulgaria, Romania, Portugal, Hungary, Ireland +15 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE plus)

Romania, Bulgaria, Belgium, Croatia, France, Greece +15 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cognitive brain circuits and the spread of tau in vivo in humans.

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

Alzheimer trials by city

Alzheimer in Toronto Alzheimer in Vancouver Alzheimer in Montreal Alzheimer in Calgary Alzheimer in Edmonton Alzheimer in Ottawa Alzheimer in Winnipeg Alzheimer in Quebec City Alzheimer in Hamilton Alzheimer in Kitchener Alzheimer in London Alzheimer in Halifax Alzheimer in New York Alzheimer in Los Angeles Alzheimer in Chicago Alzheimer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease